Dec. 15, 2022

Dave Dolan, Co-Founder & Executive Chairman at MultiFunctional Imaging

Dave Dolan, Co-Founder & Executive Chairman at MultiFunctional Imaging

Dave is the Co-Founder & Executive Chairman at MultiFunctional Imaging, a University of Utah startup company that provides software solutions for improving the efficiency and accessibility of multi-tracer imaging with PET, PET/CT, and PET/MRI scanners. Dolan’s career has been built on successes centering around the commercialization and customer adoption of innovative MedTech products/services. Spanning from Fortune 500 corporations through startups, businesses have benefitted from his track record of success in turning medical device innovation into record growth, high market share, and attractive market valuations. He is a trusted business leader who draws upon an analytical and data-driven approach with KOLs, advising boards of directors, investors, C-level executives, and other stakeholders in identifying and capitalizing on opportunities to advance each organization’s strategic vision.

WEBVTT

00:00:00.530 --> 00:00:08.599
Welcome to the Latin MedTech Leaders podcast, a conversation with MedTech leaders who have succeeded or plan to succeed in Latin America.

00:00:09.029 --> 00:00:12.240
Please subscribe on your favorite podcasting platform.

00:00:12.320 --> 00:00:14.960
Apple Podcast, Spotify, Google Podcast.

00:00:15.269 --> 00:00:17.239
Amazon Music is teacher tuning.

00:00:17.469 --> 00:00:29.199
I heard radio, Pandora, or these are welcome to the Metech Leaders podcast, a conversation with leaders who have succeeded or plan to succeed in Latin America Today.

00:00:29.201 --> 00:00:45.320
Our guest is Dave Dolan, co-founder and chairman at Multi-Functional Imaging, a company that provides software solutions for improving the efficiency and accessibility of pet, pet CT and PET MRIs scanners.

00:00:45.829 --> 00:00:52.399
Dave has a track record of success in ge, bd and j and j among other companies.

00:00:52.770 --> 00:00:54.560
So, Dave, it's great to have you here today.

00:00:54.560 --> 00:00:55.439
Welcome to the show.

00:00:55.439 --> 00:00:56.840
Oh, Julio, thank you so much.

00:00:56.841 --> 00:00:58.280
It was great to get this invitation.

00:00:59.170 --> 00:01:00.119
Awesome, Dave.

00:01:00.399 --> 00:01:02.880
All right, so let's get started talking about your journey.

00:01:02.881 --> 00:01:04.920
How is it you got to where you are today?

00:01:06.120 --> 00:01:07.799
Uh, what's your journey to Latin America?

00:01:07.801 --> 00:01:09.680
How is it you got involved with the region?

00:01:10.030 --> 00:01:10.519
Yeah.

00:01:10.920 --> 00:01:12.280
Uh, well, uh, I'm a med tech veteran.

00:01:12.390 --> 00:01:16.239
I, I started up my career at, uh, at GE Healthcare, like you, uh, brought up earlier.

00:01:16.379 --> 00:01:22.280
And, uh, I was very fortunate to be exposed to quite a few international roles and responsibilities.

00:01:23.319 --> 00:01:25.400
And, uh, Latin America was, uh, was one of those.

00:01:26.079 --> 00:01:33.159
Um, I've, uh, spent some time doing some business development work in, uh, in Mexico City, uh, Columbia, as well as, uh, Brazil.

00:01:33.959 --> 00:01:44.239
And so, uh, I, I can't, um, I can't say that, uh, I'm a, a, uh, long term veteran of doing business in Latin America, but have come to strongly respect the, uh, the marketplace.

00:01:45.819 --> 00:01:46.989
Good, good, good.

00:01:47.329 --> 00:01:51.150
And, um, let's talk about trends in Latin America.

00:01:51.150 --> 00:02:04.790
Dave, what are you seeing in the news of what do you know from experience about the region in terms of changes or trends or happening, political, economic, social disease trends, whatever, anything you can tell us about it?

00:02:04.859 --> 00:02:05.349
Yeah.

00:02:05.350 --> 00:02:07.469
Well, I, all of it's quite positive.

00:02:08.150 --> 00:02:24.710
Um, you know, I think, uh, when you're, uh, in terms of, uh, an early company, uh, which, you know, technically multi multifunctional is a common, um, commercialization or regulatory oftentimes would be to go through Europe and, uh, able to do your, your trials over there.

00:02:24.711 --> 00:02:30.069
But with, uh, mdr, that's becoming, um, untenable, you know, quite frankly, in a lot of arenas.

00:02:30.569 --> 00:02:40.229
And, uh, you know, I, I'm, I'm probably sharing nothing that the listeners to this, uh, show don't already know, in that there's a lot of first inhuman studies that are going on.

00:02:40.230 --> 00:02:43.870
I know in Intuitive is doing quite a bit of work in, uh, Chile right now.

00:02:44.710 --> 00:02:49.349
Uh, you know, and the regulatory environment is, uh, is much more favorable in Latin America.

00:02:49.550 --> 00:03:04.719
And you're seeing a, a, a, not a subtle shift from people trying to commercialize or at least do the early regulatory work in the EU or Eastern Europe, um, getting away from that and getting away from the US and doing a lot of this work in Latin America.

00:03:04.819 --> 00:03:09.800
And so it's something that is, uh, that is out there, and I don't think it's much of a surprise to anybody right now.

00:03:11.229 --> 00:03:12.520
That's an interesting point.

00:03:12.520 --> 00:03:23.479
I wrote an article about that specific topic, Dave, uh, about a year and a half ago before the U M D R was going to take, um, effect.

00:03:24.759 --> 00:03:31.080
It was supposed to take, effect or become, uh, active or a law in May before the pandemic.

00:03:31.080 --> 00:03:31.319
Right.

00:03:31.479 --> 00:03:41.879
And it was pushed a year, but I interview about 30, uh, CEOs of medical device companies about this specific trend that you're referring to.

00:03:42.340 --> 00:03:46.719
And, and, and I, and I think you're right on, on, on, on, on point.

00:03:46.721 --> 00:04:16.170
I mean, it's, uh, it's certainly a, uh, um, uh, a trend that will benefit Latin America in one way or another with clinical research and commercialization, because the, the old strategy of EU first and then the United States is being reevaluated now, I think, uh, because, uh, of the, um, the stringent requirements, and you don't have notified bodies anymore.

00:04:16.170 --> 00:04:21.088
I mean, just a few have survived, for example, and it's getting tougher and tougher to do trials.

00:04:21.180 --> 00:04:29.649
So, so yeah, we've seen a trend, um, in, in terms of the number of, of companies interested in doing first in human work in Latin America.

00:04:30.649 --> 00:04:31.930
Uh, we're being busier than ever.

00:04:32.069 --> 00:04:42.970
And, uh, we've also seen a trend of companies looking at Latin America to start commercialization after the United States, of course, and, and some other markets in, in Europe.

00:04:43.389 --> 00:04:47.209
But, um, but they're now looking at Latin America more favorably,

00:04:47.338 --> 00:04:48.009
So, yeah.

00:04:48.250 --> 00:04:48.250
Yeah.

00:04:48.730 --> 00:04:49.569
And it's changed so much.

00:04:49.571 --> 00:05:04.649
I mean, when I first started, you know, working in the med tech field 20 years ago, you know, a lot of people view Latin America as, geez, it's such a vibrant, you know, market, but boy, there's so many different regulatory fys, uh, within Latin America.

00:05:04.970 --> 00:05:07.209
It, it, it, it just didn't look attractive at the time.

00:05:08.050 --> 00:05:17.610
Um, and now the shift is going the other way where there's a lot of commonality in terms of regulatory pathways in, in Latin America, and like in our case, multifunctional imaging.

00:05:17.610 --> 00:05:24.850
We've got a five 10 K and a 5K is accepted in Latin America, in, in a lot, in a lot of Latin America, uh, territories.

00:05:24.850 --> 00:05:37.689
And so we're actually the timing of our, of our discussion is, uh, is, is, uh, pretty compelling in that we're having a board meeting the end of this week where, hey, we need a America strategy.

00:05:38.129 --> 00:05:44.170
You know, we need this market because we think we could add a tremendous amount of value.

00:05:44.470 --> 00:05:48.290
And that's something that, you know, hey, five years ago, I don't think people like me would've said.

00:05:49.689 --> 00:05:49.689
Hmm.

00:05:49.800 --> 00:05:51.410
That's, that's quite interesting.

00:05:52.088 --> 00:05:52.170
All right.

00:05:52.170 --> 00:05:56.810
So let's talk about, um, specific countries or, or your plans.

00:05:56.810 --> 00:05:59.040
Let's begin with your plans in Latin America.

00:05:59.209 --> 00:06:00.838
Do you have any specific countries in mind?

00:06:00.839 --> 00:06:06.519
Of course, you don't have to disclose confidential information, but, uh, any, any direction that you have in Latin America?

00:06:06.521 --> 00:06:13.199
Are you gonna pick specific countries first, uh, or are you gonna go for, for the big ones first and then the smaller ones?

00:06:13.201 --> 00:06:16.240
Or, you know, go for middle countries first and then the big ones?

00:06:16.269 --> 00:06:17.639
What do you have in mind terms of

00:06:18.560 --> 00:06:24.519
Yeah, we're pretty unique in that we're, we're gonna, we're gonna approach this from how our technology can best serve, uh, the markets.

00:06:25.360 --> 00:06:31.000
Um, what we do in essence is we make pet scanners or pet CT scanners and pet MRI scanners run faster.

00:06:31.459 --> 00:06:39.879
And oftentimes it's, um, older systems that our software actually delivers the most value for, because we can make older systems operate much faster.

00:06:40.838 --> 00:06:54.439
And so rather than sort of like, um, oh, we're gonna focus on Columbia because we know physicians there, or we're gonna focus on Brazil, um, we're gonna be no, where actually is the installed base available that we can take our products to?

00:06:55.240 --> 00:07:03.759
And yeah, there might, there's still, I'm sure there's still some regulatory pathway differences between, uh, the different countries, but, uh, we're gonna approach it more in terms of work.

00:07:03.761 --> 00:07:05.720
Where can we provide the best value?

00:07:05.721 --> 00:07:08.160
And where could we commercialize as quickly as possible?

00:07:09.180 --> 00:07:10.069
Yeah, yeah.

00:07:10.071 --> 00:07:10.709
Good approach.

00:07:10.711 --> 00:07:22.430
Yeah, I think that's, in your case, that's probably the best, uh, strategy and, um, going back to the issue of, um, fragmentation in Latin America.

00:07:22.430 --> 00:07:25.269
But that's because that's always been, uh, a problem.

00:07:25.740 --> 00:07:28.029
I don't know how much you know about the Pacific Alliance.

00:07:28.031 --> 00:07:43.389
You don't know, I don't know how much you know about the, the initiatives of all, well, the top countries, at least, uh, to homogenize the regulations to make them more similar in, in all these countries.

00:07:43.889 --> 00:08:00.029
And, and, uh, go, just for the listeners, um, as you correctly said, if you have CE mark or, uh, f d a approval, five[inaudible] approval in your case, uh, the pathway for approval is pre straightforward.

00:08:01.310 --> 00:08:07.069
Uh, and Columbia seems to have the fastest regulatory approval time in Latin America except for Chile.

00:08:07.071 --> 00:08:07.389
Mm-hmm.

00:08:07.470 --> 00:08:07.470
.

00:08:07.629 --> 00:08:08.470
Cause Chile doesn't have any.

00:08:08.471 --> 00:08:08.870
Right.

00:08:08.959 --> 00:08:11.629
So, uh, not many people know this.

00:08:12.069 --> 00:08:14.790
Uh, a lot of my clients get like shocked when I tell them this.

00:08:15.149 --> 00:08:17.430
Uh, Chi Chile is quite a unique country in the region.

00:08:18.509 --> 00:08:19.990
Um, but it's gonna change.

00:08:20.670 --> 00:08:36.269
And, and, and specifically because the reasons I just mentioned, which is the Pacific Alliance, Latin America's going through a transformation, um, where the countries are going, are becoming more mature, uh, countries are becoming O E C D members.

00:08:36.950 --> 00:08:57.879
Every year there's a new O E C D member which says a lot about countries being serious, about implementing best practices, best international policies and best practices on how to do business, how to do regulatory approvals, how to do social, uh, uh, uh, strategies, whatever, uh, healthcare, et cetera.

00:08:58.049 --> 00:09:16.570
So we definitely see a trend, uh, of, of having more uniform regulatory, uh, requirements and accepting reference countries, uh, Columbia, for example, and that's the case in Brazil and Mexico.

00:09:16.571 --> 00:09:25.250
They accept reference countries like the United States, Europe, uh, some of them accept Canada, some of them accept Australia, uh, Japan.

00:09:25.580 --> 00:09:29.250
So that makes things easier for foreign companies to do business in Latin America.

00:09:29.928 --> 00:09:46.289
Yeah, no, it's tremendously exciting cuz uh, you know, boy, you know, you know, 10 years ago, um, you know, people like myself saw Latin America as, as, hey, it's a, it's a, it's a excellent place to manufacture your products at, whether it be Tiana or Nogales or in Costa Rica.

00:09:46.590 --> 00:09:49.370
And now the table has completely turned up.

00:09:49.379 --> 00:09:53.808
No, actually this is a marketplace for a company as like multifunctional imaging.

00:09:55.049 --> 00:09:56.139
Yeah, yeah.

00:09:58.460 --> 00:10:19.100
And that's, and I think they've, that's how the countries in the Pacific Alliance want the block to be portrayed as, as a marketplace, if you see what they're doing for the Pacific Alliance, which is something historical, I think, because, uh, the medical sewer, do you know what that is, right?

00:10:19.379 --> 00:10:19.379
Mm-hmm.

00:10:19.460 --> 00:10:19.460
.

00:10:19.580 --> 00:10:19.580
Yep.

00:10:20.139 --> 00:10:32.820
Uh, in the south, uh, Argentina, Brazil, Uruguay, and Paraguay, they haven't really made any traction in terms of, of, of creating a, a, a, an attractive business friendly marketplace.

00:10:33.269 --> 00:10:42.629
Whereas the Pacific Alliance, since they have O A C D member countries, Chile was the first one about 10 years ago.

00:10:43.269 --> 00:10:49.549
Uh, then Colombia, then Mexico, uh, in Costa Rica, just joined in May, I think.

00:10:50.509 --> 00:10:53.870
Uh, and, uh, their Peru will join very soon.

00:10:54.370 --> 00:11:07.750
And so Panama is also, uh, in, in, in the path to, to join the, uh, alliance, but for now is only officially is Mexico, Columbia, Peru, and Chile.

00:11:08.808 --> 00:11:15.659
And the marketplace that they're creating is about 260, 200 70 million people.

00:11:16.779 --> 00:11:18.058
So they really wanna compete

00:11:18.090 --> 00:11:19.539
Just those handful of countries.

00:11:19.541 --> 00:11:20.580
That's a very big market.

00:11:21.308 --> 00:11:21.899
It is.

00:11:21.950 --> 00:11:22.500
It is.

00:11:22.500 --> 00:11:22.940
It is.

00:11:22.941 --> 00:11:23.419
Exactly.

00:11:23.428 --> 00:11:30.580
So, and the idea is to have, and I was speaking with, uh, somebody, uh, from, from that organization, um, a couple years ago.

00:11:30.581 --> 00:11:39.980
I was interviewing her, uh, in, in the adas to have a single regulatory market where if you get approval in Mexico, you gonna get instant recognition in Columbia.

00:11:41.840 --> 00:11:43.100
And that's already happening.

00:11:43.100 --> 00:11:43.779
Absolutely.

00:11:43.899 --> 00:11:44.740
It's incredibly attractive.

00:11:46.019 --> 00:11:49.779
Its, yeah, it's, it's, there's another trade block that not many people talk about.

00:11:49.780 --> 00:11:50.659
I don't know why.

00:11:51.769 --> 00:11:56.399
It's probably because they are smaller countries, but it's called the Indian Pact.

00:11:57.269 --> 00:12:02.250
The Indian P the Indian Pact are of course, the Indian countries.

00:12:02.928 --> 00:12:06.970
Uh, Colombia used to be Venezuela, not anymore, for obvious reasons.

00:12:07.178 --> 00:12:12.409
So it's Colombia, Ecuador, Peru, and Bolivia, I believes.

00:12:12.710 --> 00:12:18.129
And they're, they're, they have made it so similar to Europe, Davis, they're probably behind like 10 years.

00:12:18.149 --> 00:12:33.490
But, uh, just, uh, a couple weeks ago, I, I've read the news where a Colombian citizen can easily move to Bolivia or Ecuador and live and work and study and, and, and get a job and everything.

00:12:33.539 --> 00:12:36.289
So it is just, uh, amazing what they're doing.

00:12:36.620 --> 00:12:42.970
So they're already integrating the regulatory environment for cosmetics, for some, for food.

00:12:43.460 --> 00:12:49.690
So they're starting with, you know, low risk products, but eventually they're gonna go up to drugs and medical devices.

00:12:49.691 --> 00:12:49.970
Mm-hmm.

00:12:50.009 --> 00:12:50.049
.

00:12:50.051 --> 00:12:50.529
Yeah.

00:12:50.850 --> 00:12:52.289
No, it's an incredibly attractive market.

00:12:52.291 --> 00:12:57.090
And like you said, you know, just a handful of countries right now you said 270 million.

00:12:57.100 --> 00:12:59.169
Oh, by the way, that's about the size of the US market.

00:12:59.690 --> 00:13:00.009
That's pretty

00:13:00.139 --> 00:13:00.808
Exactly.

00:13:01.289 --> 00:13:01.289
.

00:13:02.840 --> 00:13:03.330
Yeah.

00:13:03.331 --> 00:13:03.610
Yeah.

00:13:03.610 --> 00:13:06.889
So imagine if, uh, we all get our act together in Latin America.

00:13:07.610 --> 00:13:08.450
Um, Colombian of course.

00:13:09.129 --> 00:13:20.610
And, and, uh, we as a, as a region, we are 30 something countries, over 600 million people double the size of the United States, but we have to get our act together.

00:13:20.610 --> 00:13:21.049
Come on.

00:13:21.051 --> 00:13:24.570
I mean, it is about time that we all join forces and move in the same direction.

00:13:24.769 --> 00:13:24.769
Not

00:13:24.769 --> 00:13:25.169
Everybody.

00:13:25.330 --> 00:13:30.169
Well, well, I mean, in, in, in the defense of Latin America, there's been tremendous progress over the last five years.

00:13:30.399 --> 00:13:31.090
Yeah, yeah.

00:13:31.091 --> 00:13:31.570
I agree with you.

00:13:31.571 --> 00:13:31.889
Yeah.

00:13:31.890 --> 00:13:32.090
Yeah.

00:13:32.091 --> 00:13:33.409
The countries are becoming more mature.

00:13:33.610 --> 00:13:34.210
Absolutely.

00:13:34.211 --> 00:13:34.690
Yeah.

00:13:34.691 --> 00:13:37.250
Middle class is, is growing and, and, and all that.

00:13:37.759 --> 00:13:46.129
Anyway, so going back to your experience, Dave, I'd like to dig a little, a little deeper into, into your life in Mexico or your experience in other countries.

00:13:47.090 --> 00:13:47.889
Uh, can we talk about that?

00:13:47.890 --> 00:13:53.009
I mean, what is it to be doing business in Mexico or elsewhere in, in the region?

00:13:53.010 --> 00:13:53.409
Mm-hmm.

00:13:53.450 --> 00:13:53.490
.

00:13:53.678 --> 00:13:54.169
Yeah.

00:13:54.370 --> 00:14:02.289
No, my, my, my experience has been, uh, typically with, uh, either capital equipment or with, uh, disposable products, specifically.

00:14:02.291 --> 00:14:06.529
Most of my experience in Latin America came during my tenure at, uh, Beckon Dickinson.

00:14:07.250 --> 00:14:12.210
Cause, uh, we did have a manufacturing facility, um, just outside of, uh, of, uh, Rio.

00:14:12.850 --> 00:14:21.490
And so there was, there was some, um, there were some, um, strategy meetings and, and some, uh, and some, uh, interactions that I had, uh, you know, in that area.

00:14:21.830 --> 00:14:31.330
You know, again, it was, it was always just challenging meeting with the country leaders where there was just not a lot of commonality between the marketplaces.

00:14:31.690 --> 00:14:40.289
And I'm talking, you know, this is 10, 12 years ago, there just wasn't a lot of commonality when I've would talk to the country managers and I'd be saying, geez, we have the same product.

00:14:40.710 --> 00:14:47.409
You know, why is the product, you know, priced, um, this much per piece in Columbia versus Peru?

00:14:47.950 --> 00:15:03.720
And it was, it was always a challenge where it was just, you know, geez, it's, it's difficult to have the country managers and find synergies amongst themselves, even though our product was exactly the same in delivering the exact same clinical value no matter what country it was being, being, uh, sent to.

00:15:04.019 --> 00:15:18.360
And so, uh, that was always, again, you know, the big challenge, you know, for us as a, as a mass producer of, uh, of medical devices is, you know, geez, getting to the final mile, you know, you know, to the, the facilities was always a challenge.

00:15:18.360 --> 00:15:19.799
It was never a clinical challenge.

00:15:19.801 --> 00:15:26.159
It was really more of a, of a business development challenge to be able to effectively market products, uh, correctly over there.

00:15:27.289 --> 00:15:27.929
Hmm, interesting.

00:15:28.549 --> 00:15:34.730
Did you ever have to deal with distributors or find distributors or manage distributors in the region?

00:15:34.879 --> 00:15:42.529
Yeah, it was, it was, again, it was by country because, you know, in some countries, um, you know, distribution was really the only effective way to go.

00:15:43.450 --> 00:15:59.090
Um, you know, there were, you know, countries like Brazil where we had to have a direct Salesforce, you know, because the market there expected a representative to be there upon, uh, adopting a new product, doing the in servicing and what have you.

00:15:59.500 --> 00:16:01.610
So, you know, again, it highlights what you're talking about.

00:16:01.730 --> 00:16:06.210
It was highly variable and fragmented, um, in terms of, uh, which country you're working with in Latin America.

00:16:06.940 --> 00:16:07.789
Yeah, yeah.

00:16:08.350 --> 00:16:10.309
In experience in Argentina, for example.

00:16:11.279 --> 00:16:12.590
No, actually very limited.

00:16:12.591 --> 00:16:14.070
Very limited in, in Argentina.

00:16:15.009 --> 00:16:22.789
And, and the reason I ask is because, uh, it's such a, such a difficult market, such a, uh, it's ups and downs, economic ups and downs.

00:16:22.791 --> 00:16:24.549
It's just impressive.

00:16:24.551 --> 00:16:40.470
I mean, the inflation, uh, it's just, uh, every time I have an interview like this, Argentina comes up, uh, because, uh, that's the, like, the prime example of challenges in Latin America, political changes, left, right center.

00:16:40.700 --> 00:16:41.190
Yeah.

00:16:41.470 --> 00:16:54.110
Our, our Argentina was always just a really quick discussion whenever we spoke with our country leaders, because literally the average price sold looked like our scale because of the inflation issues that you, you're speaking of.

00:16:54.529 --> 00:17:00.029
And, uh, so it was, it was just, whoa, this is really difficult for us to get our hands on.

00:17:00.330 --> 00:17:06.390
And so, uh, yeah, we, it it wasn't a strategic imperative, at least Dickinson's part to, uh, focus on that country.

00:17:07.130 --> 00:17:07.980
Yeah, yeah.

00:17:07.980 --> 00:17:08.220
Yeah.

00:17:08.250 --> 00:17:10.740
It's really a shame because it's such a developed country.

00:17:11.858 --> 00:17:23.980
Um, culturally speaking, uh, socially speaking, educationally speaking, there used to be a, a very powerful country in, in the twenties, in the thirties, absolutely.

00:17:23.980 --> 00:17:24.339
Forties.

00:17:24.340 --> 00:17:25.579
Absolutely right.

00:17:25.580 --> 00:17:26.059
Yeah.

00:17:26.060 --> 00:17:26.539
Yeah.

00:17:26.868 --> 00:17:28.858
So it's, it's really a shame.

00:17:29.339 --> 00:17:33.099
Uh, and, and Buenos Aires is one of my top places to visit in Latin America.

00:17:33.460 --> 00:17:34.700
It's a beautiful, beautiful city.

00:17:34.700 --> 00:17:35.180
Yeah.

00:17:35.181 --> 00:17:37.539
Well, that's, uh, that's a bucket list place for me.

00:17:37.900 --> 00:17:42.420
Cause everybody I know that has been to bu rs, uh, does nothing but rape about it.

00:17:42.730 --> 00:17:43.579
Yeah, yeah.

00:17:43.580 --> 00:17:43.858
Yeah.

00:17:43.859 --> 00:17:46.900
It's, it's a country full of Italians who speak Spanish.

00:17:48.858 --> 00:17:51.440
And I, I hear the best steaks in the world, is what I hear.

00:17:53.069 --> 00:17:53.960
Yeah, exactly.

00:17:53.961 --> 00:17:54.279
Yeah.

00:17:54.799 --> 00:17:58.559
Bueno Air is a beautiful mix between Madrid and Paris, actually.

00:17:58.560 --> 00:17:58.880
Yeah.

00:17:59.118 --> 00:18:01.400
And a little bit of Rome, so,

00:18:01.400 --> 00:18:01.759
Yeah.

00:18:02.118 --> 00:18:06.799
And, and, uh, multifunctional imaging we're headquartered in, uh, in, uh, salt Lake City, Utah.

00:18:07.118 --> 00:18:14.358
And so, um, as you're probably aware there, there's a, uh, a church of latter day Saints, um, Mormon, uh, culture here.

00:18:14.740 --> 00:18:18.680
And, uh, so I have a lot of friends or associates that did mission work down there.

00:18:19.240 --> 00:18:19.400
Oh, yes.

00:18:20.720 --> 00:18:21.319
Graves about Argentina.

00:18:21.920 --> 00:18:22.720
Beautiful.

00:18:23.118 --> 00:18:23.118
Yeah.

00:18:23.440 --> 00:18:23.920
I'm glad to hear that.

00:18:24.279 --> 00:18:24.279
Yeah.

00:18:24.480 --> 00:18:24.480
Yeah.

00:18:24.640 --> 00:18:24.640
Yeah.

00:18:24.799 --> 00:18:25.279
So you have to go,

00:18:26.440 --> 00:18:27.480
The bucket is,

00:18:28.660 --> 00:18:32.559
And what about Columbia and experiencing Columbia doing business in, in the country or

00:18:33.279 --> 00:18:33.279
Anything?

00:18:33.280 --> 00:18:49.240
Yeah, actually, uh, Columbia was a pretty big and strategic, uh, um, um, country for Beck Dickinson when I was there, uh, because, uh, they, even back then, um, they adhere to Thek, um, back then.

00:18:49.380 --> 00:18:55.440
And, uh, you know, obviously it's a, it's a highly, you know, developed country with, uh, a very good healthcare system.

00:18:55.740 --> 00:19:02.480
And, uh, so yeah, in, in spite the, the fact that it's, it's not the, uh, and from a population standpoint, it's not the largest marketplace.

00:19:02.589 --> 00:19:04.440
It's a highly developed marketplace.

00:19:04.618 --> 00:19:05.960
And, uh, yeah.

00:19:05.961 --> 00:19:09.960
And, uh, you know, like I said, we're gonna be meeting as a board, uh, this coming Friday.

00:19:10.140 --> 00:19:15.759
And, uh, not only are we gonna walk out with the Latin America strategy, I wanna hear what our Columbia strategy's gonna be.

00:19:15.759 --> 00:19:16.519
Beautiful.

00:19:16.579 --> 00:19:18.920
I'm really happy to hear that as a Columbian.

00:19:20.079 --> 00:19:26.599
And, and, and, and just to add, uh, to that, uh, I'm not, uh, um, this is not a commercial for Columbia.

00:19:26.920 --> 00:19:27.160
It's a fact.

00:19:28.039 --> 00:19:31.839
Uh, just like Chile is so easy to get into, Dave.

00:19:32.240 --> 00:19:36.640
Uh, I'm sure you know, as I said initially, you don't really need a regulatory registration in Chile.

00:19:36.641 --> 00:19:38.720
All you need is an importer, and you're good to go.

00:19:38.721 --> 00:19:39.400
You're in business.

00:19:40.319 --> 00:19:43.079
Uh, there is a voluntary registration process that needs to happen.

00:19:43.190 --> 00:19:56.319
What doesn't need to happen that you could do, if you wanna prepare yourself for the future, probably in the next year or so, the Congress will pass a new law where they're gonna make mandatory the regulatory registration process.

00:19:56.339 --> 00:20:05.319
The other countries of the Pacific Alliance, Chile is just getting in the same train as the other countries so that they have, uh, uh, unified sale of laws.

00:20:05.549 --> 00:20:19.960
Anyway, my point with, uh, this is that, um, uh, just as friendly as Chile is, I will say the second country in Latin America in terms of friendliness and market, ease of market access is Columbia.

00:20:20.430 --> 00:20:37.519
Just to give you a hint, the Columbia, the regulatory agency in Columbia in Vima is the only agency in Latin America that allows foreign entities to be the owners of the title holders of the registration certificate or the market clearance certificate.

00:20:37.890 --> 00:20:39.920
No other country does that.

00:20:39.990 --> 00:20:54.358
They all mandate, they all force you to have a, either a local entity or contract the services of a, what is called a registration holder, and you have to pay hefty prices for that monthly prices for other annual prices.

00:20:54.569 --> 00:21:15.099
Or even worse, they make you, uh, have the distributor as your title holder, which is not always a good idea because the distributor today may not be the shooter tomorrow, you know, that, uh, you have to probably go through two or three the shooters first before you find the, the guy, the right guy.

00:21:15.190 --> 00:21:32.819
So, um, so yeah, that says a lot about how much this country is one business, how much they want, uh, to make it easier for companies to, to enter the market, to, um, have access to patients, have access to innovative technologies faster than other countries.

00:21:32.820 --> 00:21:33.180
Right.

00:21:33.858 --> 00:21:34.618
Um, I mean, we're

00:21:35.579 --> 00:21:35.740
Panama also.

00:21:35.900 --> 00:21:35.900
Yeah.

00:21:36.099 --> 00:21:43.059
And also these countries, you know, they respect the intellectual property that, uh, technologies like multifunctional imagery bring to the table, you know?

00:21:44.099 --> 00:21:44.099
Yeah.

00:21:44.101 --> 00:21:47.500
We've made a strategic choice not to go into China, for instance.

00:21:48.420 --> 00:21:49.440
Uh, yeah.

00:21:49.759 --> 00:21:53.640
Cause we have to share some of our ip, you know, with, with their regulatory board.

00:21:53.660 --> 00:21:56.480
And, you know, quite frankly, we're, we're not quite comfortable with that.

00:21:56.920 --> 00:22:02.880
Cause we've written a lot of proprietary code, and we prefer that to be a trade secret.

00:22:03.640 --> 00:22:11.519
And, uh, and Latin America, uh, is, is is very respectful of, uh, companies like ourselves, um, in terms of that aspect.

00:22:12.289 --> 00:22:12.710
Yes.

00:22:12.711 --> 00:22:14.029
That's a, that's a great point, Dave.

00:22:14.030 --> 00:22:19.390
And the reason for that, one of the reasons for that is first the E C D, right?

00:22:19.391 --> 00:22:26.868
They, they require you to enact certain laws to protect intellectual property and other type of protections, et cetera.

00:22:27.250 --> 00:22:30.589
And second, free trade agreements, right?

00:22:30.720 --> 00:22:48.230
If you wanna have a free trade agreement with the us you, you have to comply with certain guidelines or mandates, or, or, or you agree to respect, uh, or to have a way for companies to, to, to have access to a core system in case of infringement or, or things of that nature.

00:22:48.440 --> 00:22:48.789
So,

00:22:48.789 --> 00:22:49.190
Mm-hmm.

00:22:49.509 --> 00:22:49.549
.

00:22:49.550 --> 00:22:49.990
Yeah.

00:22:50.309 --> 00:22:50.309
Yeah.

00:22:50.349 --> 00:22:56.309
Again, it's, uh, we're gonna have a Latin America strategy come this Monday.

00:22:56.789 --> 00:22:58.710
, I'm, I'm so happy to hear that, Dave.

00:22:59.029 --> 00:23:03.990
It's that it's great new for the region, it's great new for patients, it's great new for the healthcare systems of these countries.

00:23:04.450 --> 00:23:07.230
And, um, well, we're close to the end of the show.

00:23:07.539 --> 00:23:10.150
I usually keep it short to about 30 minutes.

00:23:10.618 --> 00:23:13.710
I think we covered so much in only 20 something minutes.

00:23:14.230 --> 00:23:18.789
, is there any final words of wisdom do you wanna share with the audience?

00:23:18.839 --> 00:23:27.269
If you had the ceo, e o of a medical device company in front of you, what would you say to him or her, uh, if he or she were just starting to explore Latin America?

00:23:27.589 --> 00:23:30.390
Oh, there's a fantastic opportunity in Latin America right now.

00:23:30.391 --> 00:23:31.868
My company recognizes that.

00:23:32.190 --> 00:23:35.390
And, and we're not the first, and we're not gonna be the last to, to recognize that.

00:23:36.190 --> 00:23:45.029
Um, I think that, uh, with any new market you go into, it's, it's important to identify and build tight relationships with partners that can help you.

00:23:45.079 --> 00:23:48.680
You get access to those markets, and that's where we're at right now.

00:23:48.681 --> 00:23:56.319
And it's folks like yourself, Julio, that we wanna, uh, partner with, uh, and able to, uh, take our technologies, uh, moving forward to Latin America.

00:23:56.720 --> 00:23:57.960
It's a fantastic opportunity.

00:23:58.059 --> 00:24:06.039
And, uh, you know, I think, uh, if, if you're thinking that it's gonna be a aeu strategy first, I think you need to rethink that right now.

00:24:06.040 --> 00:24:12.200
I think you need to, you know, cast your eyes upon Latin America, uh, especially for early stage companies like Multifunctional Engine.

00:24:13.440 --> 00:24:13.680
Excellent.

00:24:13.681 --> 00:24:16.279
Dave, I'm, I'm so happy to hear those words coming from you.

00:24:16.960 --> 00:24:19.400
All right, Dave, thank you again for being the show.

00:24:19.720 --> 00:24:21.200
It's being a delightful conversation.

00:24:21.220 --> 00:24:31.559
I'm sure listeners got a lot, uh, from your insights and your wisdom and your experience, and I look forward to seeing you succeed in Latin America.

00:24:32.000 --> 00:24:33.920
Oh, I look forward to, uh, speaking with you again.

00:24:33.921 --> 00:24:37.559
If there's way that we can of assistance to yourself, lu, please let us know.

00:24:38.608 --> 00:24:39.529
All excellent.

00:24:39.809 --> 00:24:39.970
All right, Dave.

00:24:40.250 --> 00:24:40.250
Thank.